Evaluation and calibration of high-throughput predictions of chemical distribution to tissues

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Pharmacokinetics and Pharmacodynamics

• Publication date

  2017-10-14

• Fields of study

  Medicine, Chemistry, Environmental Science

• Identifiers
  DOI 10.1007/s10928-017-9548-7PMID 29032447PMCID PMC6186149
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• High-throughput in-silico prediction of ionization equilibria for pharmacokinetic modeling.

  2018cited by this paper
• Drug Distribution. Part 1. Models to Predict Membrane Partitioning

  2017cited by this paper
• httk: R Package for High-Throughput Toxicokinetics.

  2017cited by this paper
• Drug Distribution Part 2. Predicting Volume of Distribution from Plasma Protein Binding and Membrane Partitioning

  2016cited by this paper
• Linking high resolution mass spectrometry data with exposure and toxicity forecasts to advance high-throughput environmental monitoring.

  2016cited by this paper
• Bayesian methods for uncertainty factor application for derivation of reference values.

  2016cited by this paper
• Informing the Human Plasma Protein Binding of Environmental Chemicals by Machine Learning in the Pharmaceutical Space: Applicability Domain and Limits of Predictability

  2016cited by this paper
• Identifiability of PBPK models with applications to dimethylarsinic acid exposure

  2015cited by this paper
• Combining the ‘bottom up’ and ‘top down’ approaches in pharmacokinetic modelling: fitting PBPK models to observed clinical data

  2015cited by this paper
• Analytical challenges for conducting rapid metabolism characterization for QIVIVE.

  2015cited by this paper
• Incorporating High-Throughput Exposure Predictions With Dosimetry-Adjusted In Vitro Bioactivity to Inform Chemical Toxicity Testing

  2015cited by this paper
• Toxicokinetic Triage for Environmental Chemicals.

  2015cited by this paper
• Exploring consumer exposure pathways and patterns of use for chemicals in the environment

  2015cited by this paper
• Predicting passive and active tissue:plasma partition coefficients: interindividual and interspecies variability.

  2014cited by this paper
• The debate on animal ADME studies in drug development: an update

  2014cited by this paper
• R: A language and environment for statistical computing.

  2014cited by this paper
• The Use of Pseudo-Equilibrium Constant Affords Improved QSAR Models of Human Plasma Protein Binding

  2013cited by this paper
• Correlation-based prediction of tissue-to-plasma partition coefficients using readily available input parameters

  2013influential reference
• Incorporating New Technologies Into Toxicity Testing and Risk Assessment: Moving From 21st Century Vision to a Data-Driven Framework

  2013cited by this paper
• Prediction of the human oral bioavailability by using in vitro and in silico drug related parameters in a physiologically based absorption model.

  2012cited by this paper
• Physiologically based pharmacokinetic/toxicokinetic modeling.

  2012cited by this paper
• Advancing prediction of tissue distribution and volume of distribution of highly lipophilic compounds from a simplified tissue-composition-based model as a mechanistic animal alternative method.

  2012influential reference
• High-performance metabolic profiling of plasma from seven mammalian species for simultaneous environmental chemical surveillance and bioeffect monitoring.

  2012cited by this paper
• Physiologically based pharmacokinetic model use in risk assessment--Why being published is not enough.

  2012cited by this paper
• Use of partition coefficients in flow-limited physiologically-based pharmacokinetic modeling

  2012cited by this paper
• A pharmacokinetic model of cis- and trans-permethrin disposition in rats and humans with aggregate exposure application.

  2012cited by this paper
• Capacities of membrane lipids to accumulate neutral organic chemicals.

  2011cited by this paper
• MEGen: A Physiologically Based Pharmacokinetic Model Generator

  2011cited by this paper
• Prediction of human blood‐to‐plasma drug concentration ratio

  2010cited by this paper
• A unified algorithm for predicting partition coefficients for PBPK modeling of drugs and environmental chemicals.

  2010cited by this paper
• A Bayesian population PBPK model for multiroute chloroform exposure

  2010cited by this paper
• Confidence Assessment of the Simcyp Time-Based Approach and a Static Mathematical Model in Predicting Clinical Drug-Drug Interactions for Mechanism-Based CYP3A Inhibitors

  2010cited by this paper
• The Simcyp® Population-based ADME Simulator

  2009cited by this paper
• Prediction of Modified Release Pharmacokinetics and Pharmacodynamics from In Vitro, Immediate Release, and Intravenous Data

  2009cited by this paper
• Development of an updated PBPK model for trichloroethylene and metabolites in mice, and its application to discern the role of oxidative metabolism in TCE-induced hepatomegaly.

  2009cited by this paper
• Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals - a report by the transatlantic think tank for toxicology (t(4)).

  2009cited by this paper
• The Simcyp population-based ADME simulator.

  2009cited by this paper
• Bayesian Calibration of a Physiologically Based Pharmacokinetic/Pharmacodynamic Model of Carbaryl Cholinesterase Inhibition

  2008cited by this paper
• Corrigendum to: ''General approach for the calculation of tissue to plasma partition coefficients" (Toxicology in Vitro 22 (2008) 457-467)

  2008cited by this paper
• Validation of a rapid equilibrium dialysis approach for the measurement of plasma protein binding.

  2008cited by this paper
• Trend Analysis of a Database of Intravenous Pharmacokinetic Parameters in Humans for 670 Drug Compounds

  2008cited by this paper
• ACToR--Aggregated Computational Toxicology Resource.

  2008cited by this paper
• General approach for the calculation of tissue to plasma partition coefficients.

  2008influential reference
• Characterizing uncertainty and variability in physiologically based pharmacokinetic models: state of the science and needs for research and implementation.

  2007cited by this paper
• Bayesian Estimation of Pharmacokinetic and Pharmacodynamic Parameters in a Mode‐of‐Action‐Based Cancer Risk Assessment for Chloroform

  2007cited by this paper
• Physiologically based pharmacokinetic modelling 2: predicting the tissue distribution of acids, very weak bases, neutrals and zwitterions.

  2006cited by this paper
• Bayesian analysis of physiologically based toxicokinetic and toxicodynamic models.

  2006cited by this paper
• Prediction of metabolic drug clearance in humans: In vitro–in vivo extrapolation vs allometric scaling

  2006cited by this paper
• Tissue distribution of basic drugs: accounting for enantiomeric, compound and regional differences amongst beta-blocking drugs in rat.

  2005cited by this paper
• Physiologically based pharmacokinetic modeling 1: predicting the tissue distribution of moderate-to-strong bases.

  2005cited by this paper
• Development of a Whole Body Physiologically Based Model to Characterise the Pharmacokinetics of Benzodiazepines. 1: Estimation of Rat Tissue-Plasma Partition Ratios

  2004cited by this paper
• Similarity to Molecules in the Training Set Is a Good Discriminator for Prediction Accuracy in QSAR

  2004cited by this paper
• Utility of hepatocytes in predicting drug metabolism: comparison of hepatic intrinsic clearance in rats and humans in vivo and in vitro.

  2003cited by this paper
• Prediction of hepatic clearance and availability by cryopreserved human hepatocytes: an application of serum incubation method.

  2002cited by this paper
• Prediction of the volume of distribution of a drug: which tissue‐plasma partition coefficients are needed?

  2002cited by this paper
• COMPARISON OF MODELS FOR THE ESTIMATION OF BIOLOGICAL PARTITION COEFFICIENTS

  2002cited by this paper
• Prediction of adipose tissue: plasma partition coefficients for structurally unrelated drugs.

  2001cited by this paper
• Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics.

  2000cited by this paper
• Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics.

  2000cited by this paper
• A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery.

  2000influential reference
• Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes.

  1999cited by this paper
• Analysis of PBPK Models for Risk Characterization

  1999cited by this paper
• Evaluation (not validation) of quantitative models.

  1998cited by this paper
• Using Structural Information to Create Physiologically Based Pharmacokinetic Models for All Polychlorinated Biphenyls: I. Tissue:Blood Partition Coefficients

  1997cited by this paper
• Using structural information to create physiologically based pharmacokinetic models for all polychlorinated biphenyls.

  1997cited by this paper
• Physiological Pharmacokinetic Analysis Using Population Modeling and Informative Prior Distributions

  1996cited by this paper
• Development of physiologically based pharmacokinetic and physiologically based pharmacodynamic models for applications in toxicology and risk assessment.

  1995cited by this paper
• Physiological Parameters in Laboratory Animals and Humans

  1993cited by this paper
• Potential error in the measurement of tissue to blood distribution coefficients in physiological pharmacokinetic modeling. Residual tissue blood. I. Theoretical considerations.

  1991cited by this paper
• Determination of octanol/water partition coefficients for hydrophobic organic chemicals with the “slow‐stirring” method

  1989cited by this paper
• Risk Assessment Extrapolations and Physiological Modeling

  1985cited by this paper
• Risk Assessment in the Federal Government: Managing the Process

  1983cited by this paper
• Toxicants and drugs: Kinetics and dynamics

  1981cited by this paper
• Robustness in the Strategy of Scientific Model Building.

  1979cited by this paper
• Report of the task group on reference man

  1979cited by this paper

• Characterizing Accuracy of Model Predictions for Chemical Concentration in High Throughput Screening Assays.

  2026cites this paper
• Applying high throughput toxicokinetics (HTTK) to per- and polyfluoro alkyl substances (PFAS)

  2026cites this paper
• Prediction variability in physiologically based pharmacokinetic modeling of tissue disposition under deep uncertainty

  2025influential citation
• Comparison of physiologically based pharmacokinetic modeling platforms for developmental neurotoxicity in vitro to in vivo extrapolation.

  2025cites this paper
• AOP-informed qIVIVE modelling for liver steatosis using triazoles

  2025cites this paper
• Collaborative evaluation of in silico predictions for high throughput toxicokinetics.

  2025cites this paper
• Applying New Approach Methods for Toxicokinetics for Chemical Risk Assessment.

  2025cites this paper
• Prediction of Internal Exposures after Virtual Oral Doses of Disparate Chemicals in Rats and Humans Using Simplified Physiologically Based Pharmacokinetic Models with In Silico-Generated Input Parameters.

  2025cites this paper
• Informatics for toxicokinetics

  2025cites this paper
• Interpretation of thyroid-relevant bioactivity data for comparison to in vivo exposures: A prioritization approach for putative chemical inhibitors of in vitro deiodinase activity.

  2025cites this paper
• Enabling transparent toxicokinetic modeling for public health risk assessment

  2025influential citation
• A Simple Physiologically Based Toxicokinetic Model for Multi-Route In Vitro–In Vivo Extrapolation

  2025cites this paper
• A Cheminformatics Workflow for Higher-throughput Modeling of Chemical Exposures from Biosolids

  2025influential citation
• Physiologically based kinetic modelling for species extrapolation of toxicokinetic data between small mammals: A systematic evaluation.

  2025cites this paper
• Impact of gut permeability on estimation of oral bioavailability for chemicals in commerce and the environment.

  2024influential citation
• Pregnancy-PBPK models: how are biochemical and physiological processes integrated?

  2023cites this paper
• Prioritization of chemicals in food for risk assessment by integrating exposure estimates and new approach methodologies: A next generation risk assessment case study

  2022cites this paper
• Prediction of Carboxylesterase 1-mediated In Vivo Drug Interaction between Methylphenidate and Cannabinoids using Static and Physiologically Based Pharmacokinetic Models

  2022cites this paper
• IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making

  2022cites this paper
• Advances in computational methods along the exposure to toxicological response paradigm.

  2022cites this paper
• Towards best use and regulatory acceptance of generic physiologically based kinetic (PBK) models for in vitro-to-in vivo extrapolation (IVIVE) in chemical risk assessment

  2022influential citation
• Evaluation of a Rapid, Generic Human Gestational Dose Model.

  2022cites this paper
• A geospatial modeling approach to quantifying the risk of exposure to environmental chemical mixtures via a common molecular target

  2022cites this paper
• Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling.

  2022cites this paper
• Incorporating Population Variability in Toxicokinetic Modeling for Risk-Based Prioritization

  2021influential citation
• GUIDANCE DOCUMENT ON THE CHARACTERISATION, VALIDATION AND REPORTING OF PBK MODELS FOR REGULATORY PURPOSES

  2021cites this paper
• High-throughput PBTK models for in vitro to in vivo extrapolation

  2021cites this paper
• Guidance document on the characterisation, validation and reporting of Physiologically Based Kinetic (PBK) models for regulatory purposes

  2021cites this paper
• In silico prediction of the full United Nations Globally Harmonized System eye irritation categories of liquid chemicals by IATA-like bottom-up approach of random forest method

  2021cites this paper
• EPA Exposure Forecasting (ExpoCast)

  2021cites this paper
• Read-Across Methodology in Toxicological Risk Assessment

  2021cites this paper
• Application of Open-Source PBPK Models in Rat-to-Human Pharmacokinetic Extrapolation of Oral Nicotine Exposure

  2021cites this paper
• Physiologically based pharmacokinetic model: distribution processes

  2020cites this paper
• Physiologically based pharmacokinetic modeling: A promising tool for translational research and regulatory toxicology

  2020cites this paper
• Physiologically-based Pharmacokinetic Modeling: a Supportive Tool to Evaluate Polychlorinated Biphenyls

  2020cites this paper
• Development and Evaluation of a High Throughput Inhalation Model for Organic Chemicals

  2020cites this paper
• Public Exposure Information on the CompTox Dashboard

  2019cites this paper
• Evaluation of phenylethylamine type entactogens and their metabolites relevant to ecotoxicology – a QSAR study

  2019cites this paper
• Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization.

  2019cites this paper
• Using the concordance of in vitro and in vivo data to evaluate extrapolation assumptions

  2019cites this paper
• Profiling 58 compounds including cosmetic-relevant chemicals using ToxRefDB and ToxCast.

  2019cites this paper
• The Next Generation Blueprint of Computational Toxicology at the U.S. Environmental Protection Agency.

  2019cites this paper
• Bioactivity screening of environmental chemicals using imaging-based high-throughput phenotypic profiling.

  2019cites this paper
• Toxicity testing in the 21st century: progress in the past decade and future perspectives

  2019cites this paper
• Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.

  2018cites this paper
• Rapid experimental measurements of physicochemical properties to inform models and testing.

  2018cites this paper
• In Vitro Methods for Pharmacokinetics: What Works and What Doesn’t for Extrapolation to In Vivo Exposures?

  2018cites this paper
• Defining toxicological tipping points in neuronal network development☆

  2018cites this paper
• Evaluating In Vitro-In Vivo Extrapolation of Toxicokinetics

  2018influential citation
• A Computational Workflow for Probabilistic Quantitative in Vitro to in Vivo Extrapolation

  2018cites this paper